CAROLE BEN-MAIMON

Insider Reports History

Location
Hayward, CA
Signature
/s/ Jennifer Johansson, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by CAROLE BEN-MAIMON:

Company Role Class Num Shares Value Price $ Report Date Ownership
Larimar Therapeutics, Inc. President and CEO, Director Common Stock 387,208 $3,384,198 $8.74 22 Jan 2025 Direct
Larimar Therapeutics, Inc. President and CEO, Director Common Stock 12,249 $107,056 $8.74 22 Jan 2025 By Trust
Larimar Therapeutics, Inc. President and CEO, Director Stock Option (Right to Buy) 546,000 22 Jan 2025 Direct
Teligent, Inc. Director Restricted Stock Units 150,000 21 Jul 2021 Direct

Insider Reports Filed by CAROLE BEN-MAIMON

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LRMR Larimar Therapeutics, Inc. 22 Jan 2025 2 $0 4 President and CEO, Director 24 Jan 2025, 16:15
LRMR Larimar Therapeutics, Inc. 17 Jan 2024 2 $0 4 President and CEO, Director 19 Jan 2024, 16:31
LRMR Larimar Therapeutics, Inc. 17 May 2023 1 +$18,525 4 President and CEO, Director 18 May 2023, 14:13
LRMR Larimar Therapeutics, Inc. 31 Jan 2023 2 $0 4 President and CEO, Director 02 Feb 2023, 19:15
LRMR Larimar Therapeutics, Inc. 16 Sep 2022 1 +$100,000 4 President and CEO, Director 19 Sep 2022, 07:00
LRMR Larimar Therapeutics, Inc. 10 May 2022 1 $0 4 President and CEO, Director 12 May 2022, 20:28
LRMR Larimar Therapeutics, Inc. 18 Jan 2022 1 $0 4 President and CEO, Director 20 Jan 2022, 18:16
/report/000110465921094965-ben-maimon-carole-2021-07-21 Teligent, Inc. 21 Jul 2021 1 $0 4 Director 22 Jul 2021, 17:04